Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab

Cancer Chemother Pharmacol. 2009 May;63(6):1157-9. doi: 10.1007/s00280-008-0859-7. Epub 2008 Nov 6.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / therapeutic use*
  • Brain Neoplasms / diagnostic imaging
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / secondary*
  • Brain Neoplasms / surgery
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / pathology*
  • Disease-Free Survival
  • Female
  • Humans
  • Injections, Spinal
  • Radiography
  • Receptor, ErbB-2 / biosynthesis*
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab